Amgen ERISA Case Doesn't Hit Proper Targets: Judge
A judge has dismissed a case brought by employee shareholders against Amgen Inc. over alleged drug safety concerns and illegal marketing that caused the biotechnology company's stock price to fall, saying...To view the full article, register now.
Already a subscriber? Click here to view full article